Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04894994
Title FLX475 in Combination With Ipilimumab in Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors RAPT Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Los Angeles Los Angeles California 90095 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Washington University School of Medicine St. Louis Saint Louis Missouri 63110 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field